logo
Select company
Select metric
$ -133.66MEarning Before Interest & Taxes (EBIT)
VS
Market
8
Sector
15
Industry
21
History
-
$ 2.11Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information

Ticker

TCRX

Company Name

TSCAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TSCAN THERAPEUTICS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TCRX - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -133.66M
3/31/2025$ -128.11M
12/31/2024$ -123.85M
9/30/2024$ -107.58M
6/30/2024$ -100.67M
3/31/2024$ -93.03M
12/31/2023$ -85.46M
9/30/2023$ -84.45M
6/30/2023$ -78.47M
3/31/2023$ -70.5M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT stands at $ -26.13M.
  • Over the past 5 years, TSCAN THERAPEUTICS INC's average EBIT has been $ -82.83M.
  • The median EBIT for TSCAN THERAPEUTICS INC during this period was $ -81.46M
  • TSCAN THERAPEUTICS INC reached its highest EBIT over the past 5 years at $ -26.13M.
  • The lowest EBIT recorded by TSCAN THERAPEUTICS INC in the same timeframe $ -133.66M

TSCAN THERAPEUTICS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
CRVO : CERVOMED INC $ -22.61MFATE : FATE THERAPEUTICS INC $ -171.52MOVID : OVID THERAPEUTICS INC $ -38.18MARMP : ARMATA PHARMACEUTICALS INC $ -12.09MCBUS : CIBUS INC $ -241.12MCUE : CUE BIOPHARMA INC $ -38.38MVERU : VERU INC $ -32.09MSRZN : SURROZEN INC $ -34.63MPSTV : PLUS THERAPEUTICS INC $ -15.3MKRRO : KORRO BIO INC $ -91.26M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

TCRX - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -133.66M

Minimum

Jun 30, 2025

$ -26.13M

Maximum

Dec 31, 2020

$ -82.83M

Average

$ -81.46M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.79M with a standard deviation of $ 130.84M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.79M
median$ 971K
std$ 130.84M